CPAP is the most effective treatment for obstructive sleep apnea, but it is not the only one — and for a significant proportion of patients, it is not a sustainable one. Whether because of mask intolerance, claustrophobia, pressure discomfort, or the simple inability to sleep with equipment attached to the face, a meaningful number of diagnosed patients either never establish CPAP use or abandon it within the first year. For these patients, the question of how to stop sleep apnea now without CPAP is not a preference — it is a practical necessity.
The answer depends heavily on the severity of the apnea, the anatomical factors driving it, and how realistic the patient is about what non-CPAP options can deliver. This guide works through the alternatives with honest assessments of their evidence, their limitations, and the patient profiles where each is most likely to succeed.
Oral Appliance Therapy — The Strongest Alternative for Most Patients
For the majority of CPAP-intolerant patients with mild to moderate sleep apnea, a custom mandibular advancement device is the most evidence-supported alternative. These devices — fabricated by a dentist experienced in sleep medicine after a thorough dental and airway evaluation — reposition the lower jaw forward during sleep, increasing the space behind the tongue and soft palate and reducing the likelihood of airway collapse.
The evidence base for oral appliances is substantial. Multiple randomized controlled trials have documented meaningful AHI reductions, improvements in oxygen saturation, reductions in daytime sleepiness, and in some studies measurable improvements in blood pressure. Head-to-head comparisons with CPAP consistently show that CPAP achieves greater average AHI reduction, but oral appliances achieve better real-world outcomes in many patients because they are used more consistently.
The limitation of oral appliance therapy is that it does not reliably achieve sufficient AHI reduction in patients with severe sleep apnea — typically defined as AHI of 30 or more. For these patients, an oral appliance may reduce severity from severe to moderate or mild, but whether that residual level of apnea is acceptable depends on the individual’s symptoms and cardiovascular risk profile, and requires a follow-up sleep study to quantify. Oral appliances are most clearly appropriate as primary therapy in mild to moderate disease and as an informed alternative in severe disease where CPAP has genuinely failed.
Positional Therapy — Highly Effective for the Right Patient
For patients whose sleep apnea is predominantly or exclusively positional — meaning events cluster in the supine position and the lateral AHI falls below clinically significant thresholds — positional therapy can be as effective as CPAP for the events it is designed to prevent.
Purpose-built positional devices using vibrotactile feedback have performed well in randomized trials specifically in positional OSA patients, with AHI reductions in lateral position that in some studies approach normal levels. Simpler approaches — positional pillows, body pillows running the length of the torso, or wedge pillows — are less well studied but effective for many motivated patients.
The critical qualifier is patient selection. Positional therapy only works where position is actually driving the events. A sleep study report that breaks down AHI by position — showing supine and lateral values separately — tells you whether you are a positional patient. If your lateral AHI is above 15 even without supine sleeping, positional therapy alone is unlikely to be an adequate treatment. If your lateral AHI is below 5 and your supine AHI is the primary driver of your diagnosis, positional therapy is a legitimate primary treatment option.
Hypoglossal Nerve Stimulation — For Specific Patients Who Have Failed CPAP
Hypoglossal nerve stimulation is a surgically implanted device that detects the breathing cycle and delivers mild electrical stimulation to the hypoglossal nerve — which controls the tongue — during each inhalation, keeping the tongue from falling posteriorly and obstructing the airway. It is activated each night before sleep with a small remote and has no external mask or tubing.
The evidence for hypoglossal nerve stimulation in appropriate candidates is strong. The STAR trial and subsequent real-world studies have demonstrated clinically significant and durable AHI reductions in patients who meet eligibility criteria, with high patient satisfaction and adherence rates considerably better than CPAP in this population.
Eligibility is specific. The procedure is generally indicated for patients with moderate to severe OSA who have failed or cannot tolerate CPAP, have a BMI below a defined threshold (typically 35), and do not have complete concentric collapse of the palate on drug-induced sleep endoscopy — a pattern associated with poor response to the therapy. It is a surgical procedure requiring general anesthesia and carries procedural risks, and it is not a first-line treatment. But for patients who meet the criteria and for whom other alternatives have been inadequate, it represents one of the more significant advances in sleep apnea treatment of the past decade.
Upper Airway Surgery — Effective When Targeted to the Right Site
Traditional upper airway surgery — uvulopalatopharyngoplasty, tonsillectomy, palatal implants, tongue base procedures — has a mixed evidence record that largely reflects the importance of patient selection. Procedures matched to the identified site of obstruction, characterized through drug-induced sleep endoscopy, produce considerably better outcomes than those applied without anatomical characterization.
Tonsillectomy in patients with significant tonsillar hypertrophy produces among the most reliable surgical outcomes in sleep apnea — particularly in younger adults where tonsils are the primary obstruction site. Maxillomandibular advancement — moving both jaws forward surgically to permanently expand the posterior airway — has among the strongest evidence of any surgical approach for carefully selected patients with craniofacial contributions to their apnea, though it is a significant procedure with a meaningful recovery period.
For patients considering surgery as an alternative to CPAP, an ENT evaluation including drug-induced sleep endoscopy is the appropriate starting point. Proceeding with surgery without anatomical characterization of the obstruction site is unlikely to produce optimal outcomes.
Myofunctional Therapy — A Useful Adjunct, Rarely Sufficient Alone
Oropharyngeal exercises — tongue and soft palate strengthening exercises practiced daily — have demonstrated modest but real AHI reductions in randomized controlled trials, most clearly in patients with mild to moderate apnea. They are not adequate as a standalone treatment for moderate to severe disease, but they are a reasonable adjunct to any of the above approaches and carry no side effects or cost beyond the time required to practice them.
Being Honest About What Non-CPAP Options Can Deliver
The alternatives to CPAP are real, evidence-supported, and appropriate for many patients. They are also, with the exception of hypoglossal nerve stimulation in selected patients, generally less reliably effective than CPAP across the full range of apnea severities. For patients considering non-CPAP options, the honest framework is: choose the most effective option you will actually use consistently, verify its effect with a follow-up sleep study, and maintain clinical follow-up to ensure treatment is working rather than assuming it is.